MedPath

Setronad

Brand Name: Setronad

Generic Name: Ondansetron (as Hydrochloride)

Active
Registration Number

DRP-12506-01

Dosage Form

Solution for Injection

Issuance Date

January 31, 2023

Expiry Date

August 22, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2mg/mL (8mg/4mL) (4mg/2mL)
PackagingType I Clear Glass Ampoule in PVC Tray x 2 mL and 4 mL (Box of 5's, 10's and 25's)

Classification

C
Classification
Prescription Drug (Rx)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ondansetron (as Hydrochloride)Active
Monograph: Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform